Objectives: The objective of this study was to compare the children's body mass index (BMI) growth between offspring exposed to maternal gestational diabetes mellitus (GDM) and those not exposed, and assess the associations between maternal hyperglycemia and their offspring's overweight risk from 1 to 6 years of age. Methods: Using the healthcare records data from the Tianjin Maternal and Child Healthcare System, we conducted a population-based cohort study, which is composed of 27,155 mother-child pairs with all mothers undergoing GDM screening test in pregnancy. Results: After adjustment for maternal and children's characteristics, children born to mothers with abnormal glucose (including GDM or abnormal glucose challenge test (GCT) but normal oral glucose tolerance test (OGTT) results) during pregnancy had higher mean values of Z-scores for BMI for age at 1, 2, 3, 5, and 6 years of age, in comparison with those born to mothers with normal glucose (all P values < 0.05). Moreover, maternal abnormal glucose was associated with a higher risk of childhood overweight with multivariate-adjusted hazard ratios of 1.07 (95% confidence interval (CI) 1.01-1.14), 1.09 (95% CI 1.04-1.15), 1.10 (95% CI 1.04-1.15), 1.08 (95% CI 1.03-1.14), 1.08 (95% 1.03-1.13), and 1.07 (95% 1.02-1.12) at 1-6 years of age compared with children of mothers with normal glucose. Conclusions: Abnormal maternal glucose tolerance during pregnancy was independently associated with children's higher BMI and overweight risk from 1 to 6 years of age. Women with positive GCT results but negative OGTT can be neglected by the health system. More attention should be paid to the health of these mothers and their offspring.
Introduction
Gestational diabetes mellitus (GDM), defined as any degree of glucose intolerance with onset or first recognition during pregnancy [1] , accounts for the majority of diabetic pregnancies. GDM affects about 7% of pregnancies in North America and has a global prevalence range from 5.8% to 12.9% [2] . The long-term risks of GDM concern both maternal and offspring's health: GDM is related to increased risk of hypertensive disorders of pregnancy, the need for cesarean delivery, and the possibility of fetal macrosomia [3] ; furthermore, women with a history of GDM have a 7-fold greater risk of developing type 2 diabetes in later life [4] ; children born to GDM mothers are also at risk of obesity, abnormal glucose metabolism [5, 6] , and adverse developmental outcomes [7] .
Unfortunately, with respect to the large number of GDMaffected population, very few studies have examined the long-term associations between the in utero exposures to maternal hyperglycemia and offspring's growth and development in early life. In the Northwestern Diabetes in Pregnancy Study in Chicago, diabetes during pregnancy (GDM and preexistent diabetes) was positively associated with the offspring's body mass index (BMI) at birth and after 5 years of age [8, 9] . The offspring of Pima Indian women with preexistent diabetes and GDM had much higher rates of obesity at age 5-19 years, compared with their counterparts born to prediabetic and nondiabetic women [10, 11] . However, these differences may be due to the high type 2 diabetes risk in the specialized population from the Pima Indians and a specialized pregnancy clinical population in Chicago [12] . Regarding the general population, two recent studies from the Hyperglycemia and Adverse Pregnancy Outcome study (HAPO) [13] and Kaiser Permanente Northwest and Hawaii [14] presented that maternal hyperglycemia increased the offspring's risk of overweight and obesity among 7-year-old girls and during the first decade among normal birth weight infants, respectively. Nonetheless, other studies did not find a clear association between maternal GDM and obesity in offspring more than 5 years old [15] [16] [17] . Moreover, at what age this association becomes apparent is unknown because very few previous studies were targeted at the GDM offspring of less than 5 years of age, and the existing results are conflicting. In the Project Viva, GDM offspring showed a slower weight gain in the first 6 months of life [18] , whereas the HAPO study in Belfast, UK, found little association between maternal glucose and obesity of offspring at 2 years of age [19] . Our previous study found that abnormal maternal glucose tolerance predicted a less weight gain in the first 3 months and more weight gain in the 9-12 months of life [20] . Discrepancies in these findings may be due to small sample sizes of GDM-exposed children, crosssectional comparison of child's obesity, and adjustment for important confounders in both mothers and children. Therefore, the present study aimed to compare the children's BMI growth between offspring exposed to maternal GDM and those not exposed, and assess the associations between maternal hyperglycemia and their offspring's overweight risk from 1 to 6 years of age in a large population.
Methods
Using the healthcare records data from the Tianjin Maternal and Child Healthcare System, we conducted a populationbased cohort study in Tianjin, China.
Tianjin Maternal and Child Healthcare System is a threetier care system, consisting of community-based health centers, district-level Women's and Children's Health Centers (also including secondary hospitals), and a citylevel (Tianjin) Women's and Children's Health Center (also including tertiary hospitals). All women are registered at their community health centers everytime they get pregnant and then referred to a secondary hospital or a tertiary hospital for healthcare from the 32nd gestational week till delivery. All children are given the health examinations at birth (<3 days after birth), and then annual examinations until 7 years of age. Every woman is assigned a unique identification number (maternal healthcare ID) at the first time she registers at the community health center and every child is assigned another unique identification number (child healthcare ID) linked with his/her biological mother's maternal healthcare ID, when he/she is born in the hospital in Tianjin. In different phases and examination locations, trained healthcare practitioners conduct the necessary examinations for pregnant women and their children, collect the data, and enter into an electronic health information system [20, 21] . Both maternal healthcare ID and child healthcare ID are "key chains" to link all the mothers' pregnancy healthcare records and their children's healthcare records until 7 years of age. Healthcare records for both pregnant women and their children have been collected and are available in the electronic form since 2009 [22] .
Healthcare records for pregnant women begin within the first 12 weeks of pregnancy, including general information (age, education, occupation, date of the first visit, numbers of pregnancy/infants, last menstrual period, expected delivery date, and smoking habits), medical history, family history of diseases, clinical measurements (height, weight, blood pressure, fasting glucose, gynecological examinations, ultrasonography, gestational diabetes screening test, and other lab tests), complications during pregnancy, pregnancy outcomes (delivery modes and labor complications), and postnatal period examinations (<42 days after delivery).
Healthcare records for children begin with children's birth, including information from newborns (date of birth, sex, gestational week of birth, birth weight, birth recumbent length, and Apgar score), postnatal period (names of the child and his/her parents, family history of diseases, feeding modalities, weight, and recumbent length), infancy (date of examination, weight, recumbent length before 24 months and height from 24 months, head circumference, number of teeth, and blood hemoglobin), and preschool (date of examination, weight, height, number of teeth, blood hemoglobin, and blood pressure), as well as the information of feeding modalities (exclusive breastfeeding, mixed breast and formula feeding, weaned from breastfeeding, and exclusive formula feeding) during the first 6 months.
Glucose testing and diagnosis
Based on recommendation from Tianjin routine prenatal care, the first antenatal visit usually happens within 4-12 gestational weeks when fasting glucose is tested among all pregnant women. At 26-30 gestational weeks, all mothers to be are screened for GDM by a two-step approach [3] . First, they submit to a glucose challenge test (GCT) by measuring the 1-h serum glucose concentration after taking 50 g glucose load in their community health centers. Then, those who have a glucose reading of ≥7.8 mmol/L are referred to the Tianjin Women's and Children's Health Center and undergo a 2-h oral glucose tolerance test (OGTT) with 75 g glucose load. GDM was diagnosed according to according to the World Health Organization (WHO) criteria: women with a 75 g glucose 2-h OGTT result confirming either diabetes (fasting glucose ≥7 mmol/L or 2 h glucose ≥11.1 mmol/L) or impaired glucose tolerance (IGT) (2 h glucose ≥7.8 mmol/L and <11.1 mmol/L). In the present study, 12 pregnant mothers were defined as isolated impaired fasting glucose (IFG), failed GCT, and fasting glucose ≥6.1 and <7.0 mmol/L and 2 h glucose <7.8 mmol/L, and these 12 mothers were included in the IGT group and treated as IGT in the clinical. Thus, in the present study, we defined women with pregnancy diabetes, IGT, or IFG as GDM or "glucose intolerance in pregnancy". For the participants with failed GCT results (1 h glucose reading ≥7.8 mmol/L) and negative OGTT results (fasting glucose <6.1 mmol/L and 2 h glucose <7.8 mmol/L), we categorized them into a group as "GCT+OGTT−". All other participants free of GDM or "GCT+OGTT−" were grouped into "normal glucose" (Fig. 1 ).
Study population
We collected the records of both mothers and their infants who were born between June 2009 and May 2011 in the six urban districts of Tianjin. A total of 43,853 mother-child pair healthcare records were available. In the present study, we included 27,155 mother-child pairs (61.9%), after excluding multiple births (n = 987), premature infants, gestational age <37 weeks (n = 1847), the mother-child pairs missing mother's weight or height information at the first prenatal visit or gestational weight gain information (n = 12,429, the mean maternal age was 28.2 years at delivery) or missing children's anthropometric data from 1 year of age (n = 1185), and the mother-child pairs with undetermined gestational glucose level due to missing GCT or OGTT results (n = 6111). We also excluded 53 participants reporting their medical history of diabetes (diagnosed before the index pregnancy) in this study and another 64 participants whose fasting glucose was ≥7.0 mmol/L before 12 gestational weeks, because they were possible to be under-diagnosed diabetes cases before pregnancy. Compared with the excluded mother-child pairs, those included in this study had younger children and were younger mothers (6.11 vs. 6.24 years at the latest follow-up point and 27.9 vs. 28.3 years at delivery, respectively) and had less male children (51.7% vs. 52.9%). The rates of child health examination at 1, 2, and 3 years (mainly administrated in community health centers) were 98.3%, 97.6%, and 98.6%, respectively, and the average rate of 4-6 years (mainly administrated in preschool) was 93.5% (6-year data were still ongoing). Our study was approved by the Human Subjects Committee of Tianjin Women's and Children's Health Center (TWCHC) and conformed to the guidelines of the Helsinki agreement and its amendments. Since we used the electronic healthcare records in this study, TWCHC agreed to waive the need for written informed consent from all participants.
Patient involvement
We used the electronic healthcare records from Tianjin Maternal and Child Healthcare System. No patients were involved in this study.
Measurements
Using the standardized protocol, all mothers' height and weight were measured in light indoor clothing and without shoes by trained practitioners in community health centers during the pregnancy. Women's gestational weight gain (GWG) was calculated as the difference between prepregnancy and delivery weight. Maternal BMI was calculated by dividing weight in kilograms by the square of height in meters. We treated maternal BMI using the weight and height measured at the first prenatal visit within the first 12 weeks of the index pregnancy as prepregnancy BMI [23] . According to the Chinese BMI cut-offs [24] , maternal prepregnancy BMI was further categorized as four groups: <18.5, 18.5-23.9, 24.0-27.9, and ≥28.0 kg/m 2 . Meanwhile, we categorized the women according to the WHO classification and IOM (Institute of Medicine) guidelines [25] . Women with a GWG within the IOM-recommended range were categorized as having an adequate GWG, those with a GWG less than the lower limit were categorized as having an inadequate GWG, and those with a GWG greater than the upper limit were categorized as having an excessive GWG.
Children's anthropometric data, including body weight, height, or recumbent length (before 24 months), were collected at birth (<3 days after birth) in delivery hospitals by nurses, every year between 1 year and 3 years in community health centers by trained health practitioners, and every year between 3 years and 7 years in preschool by Tianjin or district-level Women's and Children's Health Center(s), using the same devices. Measurement devices and standards have been described elsewhere [21, 26] . Validity studies were also conducted to compare the healthcare records and measurements [21] . The correlations between electronic healthcare records and measurement data for pregnancy women and children are 0.998 and 0.999 (for body weight) as well as 0.997 and 0.999 (for height/recumbent length), respectively.
Children's Z-scores for body mass index and childhood overweight Z-score for BMI for age (Z-BMI) was used to describe the change in the offspring's BMI. It is a gender-independent classification system, representing equivalent BMI-for-age percentile based on the WHO growth reference [27] . Children's Z-BMI (from 1 to 6 years of age) was calculated based on the protocol from the WHO. We also defined childhood obesity by Z-scores. Although BMI under 2 years of age was not recommended for clinical use [28] and there was no universal agreement on the definition of obesity in toddlers under 2 years of age [29] , in order to describe a child's growth using the same standard from 1 to 6 years of age (weight-for-length Z-score is not available after 5 years of age), we defined normal weight as a BMI less than the 85th percentiles for age and gender based on the WHO growth reference (Z-score < 1.035) and overweight as a BMI above the 85th percentiles (Z-score ≥ 1.035) [29] . Childhood overweight was evaluated as a time-tooverweight analysis [14] ; we counted the first measurement of overweight as a case and accumulated the cases from age 1 to 6 years.
Statistical analyses
We used one-way analysis of variance and chi-square test to compare the general characteristics (continuous and categorical variables) of both mothers and children according to maternal glucose level in pregnancy (normal glucose, GCT +OGTT−, and GDM). General linear models were applied to assess the differences in children's Z-BMI at 1 year (±6 months), 2 years (±6 months), 3 years (±6 months), 4 years (±6 months), 5 years (±6 months), and 6 years (±6 months) of age according to maternal glucose level in pregnancy. Cox proportional hazards models were used to estimate hazards ratios for childhood overweight at 1 to 6 years of age according to maternal glucose level in pregnancy. We also stratified the participants by children's gender and assessed the associations of maternal glucose level in pregnancy and childhood overweight among boys and girls, respectively. The analyses included three multivariable-adjusted models: Model 1 adjusted for maternal age, gestational age, education, smoking status, and infant feeding modes; Model 2 adjusted for the variables in Model 1 and also for maternal gestational weight gain; Model 3 adjusted for the variables in Model 2 and also for maternal prepregnancy BMI. All the analyses were performed using IBM SPSS Statistics 24.0 (IBM SPSS, Chicago, IL) with a statistical significance at 0.05.
Results
Of all the 27,155 mother-child pairs, 5.5% of mothers were diagnosed with GDM (including pregnancy DM with fasting glucose level ranging from 4.16 to 12.22, 2 h glucose level ranging from 7.80 to 20.56, IGT with fasting glucose level ranging from 3.63 to 6.85, 2 h glucose level ranging from 7.80 to 11.09, IFG with fasting glucose level ranging from 6.10 to 6.51, and 2 h glucose level ranged from 6.10 to 7.68), whereas 8.0% of mothers had a failed GCT test and passed the OGTT test (GCT+OGTT−). The general maternal and child characteristics according to maternal glucose level in pregnancy (normal glucose, GCT +OGTT−, and GDM) are presented in Table 1 . Mothers with GDM were older and had a higher prepregnancy BMI and less gestational weight gain compared with mothers Values are means ± SD unless otherwise specified BMI body mass index, GCT glucose challenge test, OGTT oral glucose tolerance test, GDM gestational diabetes mellitus with normal glucose during pregnancy. Children born to mothers with normal glucose during pregnancy had lower means of Z-BMI, in comparison with those children born to mothers with GDM or GCT+OGTT− at 1, 2, 3, and 5 years of age in an unadjusted model. Table 2 presents the comparison of children's Z-BMI from 1 to 6 years of age according to maternal glucose level in pregnancy. After adjustment for maternal age, education, smoking status, gestational age, weight gain during pregnancy, and infant feeding modes (multivariable-adjusted Model 2), children born to mothers with normal glucose during pregnancy had lower mean values of Z-BMI at 1 to 6 years of age, in comparison with those children born to mothers with GDM or GCT+OGTT− (all P values < 0.05). The multivariable-adjusted mean values of Z-BMI in children born to mothers with normal glucose, GCT +OGTT−, and GDM during pregnancy were 0.65, 0.75, and 0.75 at 1 year of age (P value < 0.001), 0.42, 0.52, and 0.54 at 2 years of age (P value < 0.001), 0.26, 0.35, and 0.38 at 3 years of age (P value < 0.001), 0.16, 0.21, and 0.25 at 4 years of age (P value = 0.007), 0.18, 0.28, and 0.34 at 5 years of age (P value < 0.001), and 0.25, 0.35, and 0.40 at 6 years of age (P value = 0.003), respectively. When introducing maternal prepregnancy BMI into the model (multivariable-adjusted Model 3), the differences were still significant among children at 1, 2, 3, and 5 years of age, and disappeared among children at 4 and 6 years of age.
Since the mean values of Z-BMI had no significant differences between children born to mothers with GCT +OGTT− and those born to mothers with GDM during pregnancy at each age group of 1-6 (P values for difference > 0.05), we combined children born to mothers with GCT +OGTT− and GDM into one group and regrouped all mother-child pairs into two groups: children with normal glucose mothers and children with abnormal glucose (GCT +OGTT− or GDM) mothers in the analyses (Fig. 2) . In multivariable-adjusted Model 3, children born to mothers with normal glucose during pregnancy had significantly lower mean values of Z-BMI at 1, 2, 3, 5, and 6 years of age (but not 4 years old) than those born to mothers with abnormal glucose.
In addition, we performed a sensitive analysis including 1632 mother-child pairs with mothers having failed GCT but without OGTT results (these mothers and children were both older than the originally included mothers and children: 28.5 vs. 27.9 and 6.3 vs. 6.1, respectively, but the distributions of children's gender were similar) in the abnormal glucose group (GCT+OGTT−, or GCT+ but without OGTT, or GDM), and found that children born to mothers with abnormal glucose during pregnancy had significantly higher mean values of Z-BMI at 1, 2, 3, 4, 5, and 6 years of age than those born to mothers with normal glucose during pregnancy (Online Table1).
The hazard ratios of childhood overweight according to maternal glucose level in pregnancy are shown in Table 3 . Compared with children born to mothers with normal glucose during pregnancy, children with GDM mothers showed 10-17% increased multivariable-adjusted risks of childhood obesity from 1 to 6 years of age, while children born to mothers with GCT+OGTT− status during pregnancy showed 12-16% increased multivariable-adjusted risks of childhood obesity. After additional adjustment for maternal prepregnancy BMI, the increased hazard ratios of childhood overweight somewhat attenuated but still remained significant in almost all groups of children born to mothers with GCT+OGTT− or GDM at different age groups. Since we found little difference between GCT +OGTT− and GDM on childhood overweight risk at all ages, we combined these two groups into one group, refit the models, and found that maternal abnormal glucose (GCT+OGTT− or GDM) during pregnancy was independently associated with a higher risk of childhood overweight at each age group of 1-6 years (multivariableadjusted Model 3). Moreover, we conducted the models with GWG in categorical variables (inadequate, adequate, and excessive), instead of the continuous variables, and the associations were consistent (Online Table 2 ).
When stratified by sex of the child, the positive associations between maternal abnormal glucose in utero and the risk of childhood overweight were significant at almost each age group of 1-6 years among boys and at 3 years of age among girls (Online Table 3 ). There were no significant interactions between maternal abnormal glucose in utero and GDM and the child's sex with the risk of childhood overweight (P value for interaction is all over 0.05).
Discussion
In the present study, we found that maternal hyperglycemia including either GCT+OGTT− or GDM during pregnancy was associated with higher values of Z-scores for BMI for age and increased risks of overweight in children at each year up to 6 years of age, and these associations were independent of maternal prepregnancy BMI and other related maternal and infant factors.
The worldwide rise in over-nutrition, sedentary life, and obesity has resulted in a steep increase in the number of women who develop GDM during pregnancy [3] . Previous studies have indicated that in utero exposure to GDM is a risk factor of macrosomia and large for gestational age at birth and developing obesity and type 2 diabetes during adolescence or young adulthood in the offspring [30] . There is a public debate on the associations between maternal Fig. 2 Comparison of Z-scores for body mass index for age at 1, 2, 3, 4, 5, and 6 years of age between children born to mothers with normal glucose and abnormal glucose (GCT+OGTT− or GDM) during pregnancy. Adjusted for maternal age, education, smoking status, prepregnancy body mass index, gestational age at delivery, gestational weight gain and infant feeding modes hyperglycemia and offspring's overweight and obesity. Studies of Northwestern diabetes in pregnancy study in Chicago [8, 9] , Pima Indian [11] , HAPO [13] , and Kaiser Permanente centers [14] claimed to find a positive association, while other studies argued that little association existed [15] [16] [17] . However, most of previous studies were targeted at the GDM's offspring at birth or of more than 5 years of age. Therefore, at what age these associations become apparent is still unknown.
Within the research conducted among children under 5 years of age, the Project Viva observed that children born to mothers with GDM and IGT had a slower weight gain in the first 6 months of life, compared with those infants with normal glucose tolerance mothers [18] . Our previous study found that abnormal maternal glucose tolerance during pregnancy predicted a less weight gain in the first 3 months and more weight gain in the 9-12 months of life in the offspring [20] . On the contrary, the HAPO study in Belfast [19] and the Exploring perinatal Outcomes among Children (EPOCH) study in Colorado [31] found no association of maternal hyperglycemia with the growth of offspring at 2 years of age and before 26 months, respectively. The differences may be due to limited sample sizes of GDM and different adjustments in the analysis. The present study indicated that both maternal GCT+OGTT− and maternal GDM during pregnancy were associated with higher values of Z-scores for BMI for age and increased risks of overweight in children at 1, 2, 3, 4, 5, and 6 years of age, and these associations were independent of maternal prepregnancy BMI and other related maternal and infant factors. Our study was intended to contribute to the limited amount of literature examining this association, especially for large population-based studies among children under 5 years of age. In the present study, we also controlled various covariates in the multivariable-adjusted analysis, such as maternal social-economic characteristics, lifestyle, infant feeding status, maternal weight gain during pregnancy, and prepregnancy BMI, which were identified as important confounders of this association [32] . Also, adjusting for maternal obesity could help to determine and understand the causes of offspring obesity: an altered intrauterine environment or obesity genes inherited from the mother [15] . Moreover, a novel finding from the present study is that children exposed to maternal abnormal glucose in utero, including GDM and GCT+OGTT− status, had the same risk of childhood overweight. Either GDM or GCT +OGTT− mothers during pregnancy had an increased risk on offspring's overweight at 1-6 years of age, compared mothers with normal glucose in pregnancy. According to the Pregnancy Infection and Nutrition study (PIN), a study performed among children born to the mothers with normal glucose level during pregnancy, maternal glucose concentration of ≥130 mg/dL was independently associated with the development of overweight/obesity at 3 years of age [33] . Therefore, more attention should be paid on the health of children born to women with positive GCT results but negative OGTT results in pregnancy.
The possible explanation underlying these findings could be "maternal abnormal metabolic imprinting", which represented a determinant of an over-nutritional status of fetus and further leading to offspring's diseases later in life [34] . One of the mechanisms may be the delivery of excessive nutrients from mothers to the fetus; that maternal glucose but not insulin can cross the placenta would in turn influence the development of fetus in utero and even longterm health [35] . Simultaneously, we learned from the study of Pima Indian families that a greater number of diabetessusceptibility genes may be inherited from mothers with hyperglycemia to their offspring [36] .
In the present study, we also found little difference of children's Z-BMI at 4 years of age between the normal glucose group and abnormal glucose (GCT+OTTT− or GDM) groups. A possible explanation may be that the nadir of all children's Z-BMI was around their 4 years of age. The results were consistent with our previous work, which used a large health survey of 3-6-year-old children between 2006 and 2014 in Tianjin and suggested that the lowest mean value of Z-BMI appeared around 4 years of age [37] .
Our study is a large-scale population-based study of mother-child pairs from the prenatal period to early childhood with anthropometry measurements by trained health practitioners. Also, the data are based on the Asian population, who are of increasing burden of childhood obesity and diabetes; as such, identification and understanding of early life risk factors are particularly relevant. However, there are some limitations in our study. First, 38.1% of mother-child pairs were excluded from the present study due to missing values. Although we have adjusted for maternal age and used Z-score independent of children's age to describe the growth of children, the results still might differ from the true value because of the imbalance. Second, since we used healthcare records as a main source of data, some childhood lifestyle factors, such as physical activity and nutrition, were not available in this study. Third, we excluded premature and multiple birth infants and the information of assisted reproductive technology pregnancies was not available in this study, and therefore, we should be cautious when generalizing the findings.
In conclusion, abnormal maternal glucose tolerance during pregnancy was independently associated with children's higher BMI and overweight risk from 1 to 6 years of age. Women with positive GCT results but negative OGTT can be neglected by the health system. Therefore, health services should pay more attention to the health of these mothers and to the health of their offspring.
